Market Closed -
Toronto S.E.
04:00:00 2024-05-31 pm EDT
|
5-day change
|
1st Jan Change
|
6.99
CAD
|
+2.04%
|
|
+5.11%
|
+0.43%
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
2,716
|
1,656
|
1,311
|
1,321
|
-
|
Enterprise Value (EV)
1 |
3,728
|
2,605
|
2,319
|
2,318
|
2,312
|
P/E ratio
|
-13.3
x
|
-98.9
x
|
-15.1
x
|
-28.7
x
|
-87.5
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
2.63
x
|
1.32
x
|
0.92
x
|
0.85
x
|
0.77
x
|
EV / Revenue
|
3.62
x
|
2.08
x
|
1.63
x
|
1.5
x
|
1.35
x
|
EV / EBITDA
|
19.4
x
|
11.3
x
|
8.93
x
|
8.15
x
|
7.25
x
|
EV / FCF
|
92
x
|
28.8
x
|
18.3
x
|
17
x
|
13.6
x
|
FCF Yield
|
1.09%
|
3.47%
|
5.47%
|
5.88%
|
7.35%
|
Price to Book
|
1.81
x
|
0.93
x
|
0.75
x
|
0.77
x
|
0.77
x
|
Nbr of stocks (in thousands)
|
166,911
|
186,034
|
188,413
|
188,952
|
-
|
Reference price
2 |
16.27
|
8.900
|
6.960
|
6.990
|
6.990
|
Announcement Date
|
3/25/22
|
3/23/23
|
3/22/24
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
-
|
1,031
|
1,250
|
1,426
|
1,546
|
1,715
|
EBITDA
1 |
-
|
191.8
|
230.6
|
259.7
|
284.3
|
318.7
|
EBIT
1 |
-
|
-81.5
|
40.3
|
56.6
|
113.2
|
157.8
|
Operating Margin
|
-
|
-7.91%
|
3.22%
|
3.97%
|
7.33%
|
9.2%
|
Earnings before Tax (EBT)
1 |
-
|
-171.2
|
-77.4
|
-102.5
|
-21
|
19
|
Net income
1 |
-169.2
|
-160.4
|
-16.6
|
-85.6
|
-23.97
|
-8.724
|
Net margin
|
-
|
-15.56%
|
-1.33%
|
-6%
|
-1.55%
|
-0.51%
|
EPS
2 |
-1.890
|
-1.220
|
-0.0900
|
-0.4600
|
-0.2437
|
-0.0799
|
Free Cash Flow
1 |
-
|
40.5
|
90.4
|
126.9
|
136.4
|
170
|
FCF margin
|
-
|
3.93%
|
7.23%
|
8.9%
|
8.82%
|
9.91%
|
FCF Conversion (EBITDA)
|
-
|
21.12%
|
39.2%
|
48.86%
|
47.98%
|
53.35%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
4/30/21
|
3/25/22
|
3/23/23
|
3/22/24
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
272.5
|
280.2
|
327
|
312.1
|
331
|
358.3
|
368.3
|
336.9
|
362.2
|
372.4
|
395.9
|
374.3
|
403.1
|
413.2
|
418.4
|
EBITDA
1 |
50.1
|
50.1
|
59.8
|
59.3
|
60.6
|
65.6
|
67
|
60.9
|
65.8
|
68.1
|
72.56
|
68.74
|
74.98
|
76.78
|
77.9
|
EBIT
1 |
-16.37
|
8.6
|
11.8
|
9.6
|
9.5
|
5.8
|
16.5
|
10.7
|
15.1
|
17.3
|
30.27
|
25.98
|
33.33
|
-
|
-
|
Operating Margin
|
-6.01%
|
3.07%
|
3.61%
|
3.08%
|
2.87%
|
1.62%
|
4.48%
|
3.18%
|
4.17%
|
4.65%
|
7.65%
|
6.94%
|
8.27%
|
-
|
-
|
Earnings before Tax (EBT)
|
-42
|
-24.5
|
-2.8
|
-16.9
|
-33.3
|
-
|
-
|
-12.6
|
-43.1
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
1 |
-43.1
|
-11
|
2.4
|
-14.7
|
6.6
|
-33.3
|
-7.3
|
-9.8
|
-35.1
|
-11.7
|
-10.2
|
-13.5
|
-7.2
|
-
|
-
|
Net margin
|
-15.82%
|
-3.93%
|
0.73%
|
-4.71%
|
1.99%
|
-9.29%
|
-1.98%
|
-2.91%
|
-9.69%
|
-3.14%
|
-2.58%
|
-3.61%
|
-1.79%
|
-
|
-
|
EPS
2 |
-0.2400
|
-0.0600
|
0.0100
|
-0.0800
|
0.0400
|
-0.1800
|
-0.0400
|
-0.0500
|
-0.1900
|
-
|
-0.0442
|
-0.0429
|
-0.0421
|
-0.0360
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/25/22
|
5/10/22
|
8/12/22
|
11/9/22
|
3/23/23
|
5/12/23
|
8/4/23
|
11/8/23
|
3/22/24
|
5/10/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
1 |
-
|
1,012
|
950
|
1,008
|
997
|
991
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
5.276
x
|
4.118
x
|
3.88
x
|
3.508
x
|
3.109
x
|
Free Cash Flow
1 |
-
|
40.5
|
90.4
|
127
|
136
|
170
|
ROE (net income / shareholders' equity)
|
-
|
5.68%
|
7.11%
|
3.76%
|
5.36%
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
-
|
9.000
|
9.590
|
9.220
|
9.080
|
9.020
|
Cash Flow per Share
2 |
-
|
0.4200
|
0.7600
|
0.8200
|
1.010
|
1.080
|
Capex
1 |
-
|
14.6
|
23.9
|
26.5
|
29.3
|
29.3
|
Capex / Sales
|
-
|
1.42%
|
1.91%
|
1.86%
|
1.9%
|
1.71%
|
Announcement Date
|
4/30/21
|
3/25/22
|
3/23/23
|
3/22/24
|
-
|
-
|
Last Close Price
6.99
CAD Average target price
10.04
CAD Spread / Average Target +43.56% Consensus |
1st Jan change
|
Capi.
|
---|
| +0.43% | 968M | | +25.52% | 88.99B | | -24.52% | 74.82B | | +0.49% | 26.63B | | +4.31% | 17.88B | | -14.25% | 16.43B | | +2.97% | 15.77B | | +79.20% | 13.21B | | +70.11% | 13.08B | | +40.44% | 12.9B |
Other Healthcare Facilities & Services
|